ATE355301T1 - Moraxella catharralis proteine - Google Patents

Moraxella catharralis proteine

Info

Publication number
ATE355301T1
ATE355301T1 AT99921008T AT99921008T ATE355301T1 AT E355301 T1 ATE355301 T1 AT E355301T1 AT 99921008 T AT99921008 T AT 99921008T AT 99921008 T AT99921008 T AT 99921008T AT E355301 T1 ATE355301 T1 AT E355301T1
Authority
AT
Austria
Prior art keywords
proteins
moraxella catharralis
catharralis
moraxella
catarrhalis
Prior art date
Application number
AT99921008T
Other languages
English (en)
Inventor
Allan William Cripps
Jennelle Kyd
Original Assignee
Provalis Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis Uk Ltd filed Critical Provalis Uk Ltd
Application granted granted Critical
Publication of ATE355301T1 publication Critical patent/ATE355301T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AT99921008T 1998-05-11 1999-05-11 Moraxella catharralis proteine ATE355301T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810084.5A GB9810084D0 (en) 1998-05-11 1998-05-11 Proteins

Publications (1)

Publication Number Publication Date
ATE355301T1 true ATE355301T1 (de) 2006-03-15

Family

ID=10831854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921008T ATE355301T1 (de) 1998-05-11 1999-05-11 Moraxella catharralis proteine

Country Status (20)

Country Link
US (2) US7557185B2 (de)
EP (2) EP1077999B1 (de)
JP (1) JP4782281B2 (de)
KR (1) KR20010071236A (de)
CN (2) CN101684147A (de)
AT (1) ATE355301T1 (de)
AU (1) AU769020B2 (de)
CA (1) CA2328130A1 (de)
CY (1) CY1107636T1 (de)
DE (1) DE69935323T2 (de)
DK (1) DK1077999T3 (de)
ES (1) ES2284254T3 (de)
GB (1) GB9810084D0 (de)
IL (1) IL139495A0 (de)
NO (1) NO20005670L (de)
NZ (3) NZ528725A (de)
PT (1) PT1077999E (de)
RU (1) RU2000131225A (de)
WO (1) WO1999058563A2 (de)
ZA (1) ZA200006489B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
ES2306662T3 (es) * 1999-05-24 2008-11-16 Glaxosmithkline Biologicals S.A. Nuevos compuestos de moraxella catarrhalis.
WO2002092625A2 (en) 2001-05-15 2002-11-21 Shire Biochem Inc. Moraxella(branhamella) catarrhalis antigens
AU2002342466A1 (en) 2001-11-16 2003-06-10 Id Biomedical Corporation Polypeptides of moraxella (branhamella) catarrhalis
WO2008046228A1 (en) * 2006-10-19 2008-04-24 Angiochem, Inc. Compounds for stimulating p-glycoprotein function and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5993826A (en) * 1993-03-02 1999-11-30 Board Of Regents, The University Of Texas Methods and compositions relating to useful antigens of moraxella catarrhalis
US5552146A (en) 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5607846A (en) * 1994-05-17 1997-03-04 Research Foundation Of State University Of New York Vaccine for moraxella catarrhalis
US6121427A (en) * 1994-10-24 2000-09-19 Connaught Laboratories Limited Major outer membrane protein CD of branhamella
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US7341727B1 (en) 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
US6004562A (en) * 1996-08-16 1999-12-21 The Research Foundation Of The State University Of New York Outer membrane protein B1 of Moraxella catarrhalis
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
ES2306662T3 (es) 1999-05-24 2008-11-16 Glaxosmithkline Biologicals S.A. Nuevos compuestos de moraxella catarrhalis.

Also Published As

Publication number Publication date
DE69935323D1 (de) 2007-04-12
NZ537460A (en) 2005-12-23
IL139495A0 (en) 2001-11-25
CY1107636T1 (el) 2013-04-18
ES2284254T3 (es) 2007-11-01
DK1077999T3 (da) 2007-05-29
CN1306542A (zh) 2001-08-01
GB9810084D0 (en) 1998-07-08
NO20005670L (no) 2001-01-10
EP1849800A3 (de) 2007-12-05
EP1077999B1 (de) 2007-02-28
AU769020B2 (en) 2004-01-15
JP4782281B2 (ja) 2011-09-28
WO1999058563A3 (en) 1999-12-29
AU3838399A (en) 1999-11-29
US7557185B2 (en) 2009-07-07
NZ508004A (en) 2003-11-28
WO1999058563A2 (en) 1999-11-18
PT1077999E (pt) 2007-06-06
NO20005670D0 (no) 2000-11-10
EP1077999A2 (de) 2001-02-28
CN101684147A (zh) 2010-03-31
KR20010071236A (ko) 2001-07-28
DE69935323T2 (de) 2008-01-17
US20090246228A1 (en) 2009-10-01
CA2328130A1 (en) 1999-11-18
NZ528725A (en) 2005-02-25
EP1849800A2 (de) 2007-10-31
US20040005328A1 (en) 2004-01-08
JP2002514657A (ja) 2002-05-21
ZA200006489B (en) 2002-08-12
RU2000131225A (ru) 2003-05-27

Similar Documents

Publication Publication Date Title
ATE361365T1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
DE69529219T2 (de) Helicobacter proteine und impstoffe
CY1114722T1 (el) Αντιγονα στρεπτοκοκκου
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
NO976119D0 (no) OMP26-antigen fra Haemophilus influenzae
DK1181319T3 (da) Kimære DR4-antistoffer og anvendelser deraf
TR199800679T2 (xx) Kiral metil fenil oksazolidinon.
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
PT946873E (pt) Metodos para diagnostico da aspergilose broncopulmonar alergica
CY1107636T1 (el) Πρωτεϊνες moraxella catarrhalis
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
IT1317849B1 (it) Mezzi e metodi per l'espressione di proteine omologhe ed eterologhe inceppi di rhodococcus.
DE69232975D1 (de) Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung
NO970130D0 (no) Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener
BR0303226A (pt) Proteìnas de aderência e penetração de haemophilus
ATE105335T1 (de) Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077999

Country of ref document: EP